Cid Puente Ricardo, Aguirre Moreno Paola D, Barrios Muñoz America M, Garcia Luis Ashley M, Contreras Saenz Claudia P
Department of Immunology, Biological Sciences School, Universidad Autónoma de Zacatecas, Zacatecas, MEX.
Department of Internal Medicine, Centenario Hospital Miguel Hidalgo, Aguascalientes, MEX.
Cureus. 2025 Apr 30;17(4):e83280. doi: 10.7759/cureus.83280. eCollection 2025 Apr.
Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism that manifests as recurrent episodes of flaccid paralysis, hypokalemia, and thyrotoxicosis. It can occur in patients with or without a prior diagnosis of hyperthyroidism, and its diagnosis is relatively straightforward once low serum potassium levels and elevated thyroid hormones are evident. However, due to the rarity of the disease, it is seldom the primary diagnosis, and a differential diagnosis must be made with other neurological diseases that resemble the paralysis picture, including Guillain-Barre syndrome. Treatment consists of potassium replacement and management of hyperthyroidism. In this article, we present the clinical case of a previously healthy 24-year-old Latino patient without a history of hyperthyroidism who rapidly developed quadriplegia following intramuscular dexamethasone administration. During his hospital stay, severe hypokalemia and elevated serum thyroid hormone levels were evident, leading to the diagnosis of TPP. Treatment with intravenous potassium and antithyroid medications was initiated, resulting in complete remission of the condition and recovery of mobility in all four limbs. Subsequently, a thyroid ultrasound revealed a thyroid nodule as the cause of thyrotoxicosis. The aim of this work is to raise awareness of a rare disease in the Mexican population, its clinical characteristics, complications, and appropriate treatment and control of recurrent episodes.
甲状腺毒症性周期性瘫痪(TPP)是甲状腺功能亢进症的一种罕见并发症,表现为反复发作的弛缓性麻痹、低钾血症和甲状腺毒症。它可发生于既往有或无甲亢诊断的患者,一旦血清钾水平降低和甲状腺激素升高明显,其诊断相对简单。然而,由于该病罕见,很少作为首要诊断,必须与其他类似麻痹表现的神经系统疾病进行鉴别诊断,包括吉兰-巴雷综合征。治疗包括补钾和甲亢的管理。在本文中,我们介绍了一名既往健康的24岁拉丁裔患者的临床病例,该患者无甲亢病史,在肌肉注射地塞米松后迅速出现四肢瘫痪。在他住院期间,明显出现严重低钾血症和血清甲状腺激素水平升高,从而诊断为TPP。开始静脉补钾和抗甲状腺药物治疗,病情完全缓解,四肢恢复活动能力。随后,甲状腺超声检查发现一个甲状腺结节是甲状腺毒症的病因。这项工作的目的是提高墨西哥人群对这种罕见疾病的认识,包括其临床特征、并发症以及复发性发作的适当治疗和控制。